Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
340.22
-4.63 (-1.34%)
Feb 21, 2025, 4:00 PM EST - Market closed
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $10.37 billion as of February 21, 2025. Its market cap has increased by 11.64% in one year.
Market Cap
10.37B
Enterprise Value
9.85B
1-Year Change
11.64%
Ranking
Category
Stock Price
$340.22
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $10.37B, an increase of 840.86%. That is a compound annual growth rate of 30.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 10.37B | 0.38% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 783.95B |
| UnitedHealth Group | 466.20B |
| Johnson & Johnson | 383.00B |
| Novo Nordisk | 370.06B |
| AbbVie | 350.42B |
| Abbott Laboratories | 229.05B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.48B |